These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25572516)

  • 1. The natural course of healthy obesity over 20 years.
    Bell JA; Hamer M; Sabia S; Singh-Manoux A; Batty GD; Kivimaki M
    J Am Coll Cardiol; 2015 Jan; 65(1):101-102. PubMed ID: 25572516
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.
    Hashimoto Y; Hamaguchi M; Fukuda T; Ohbora A; Kojima T; Fukui M
    Endocrine; 2017 Jul; 57(1):89-97. PubMed ID: 28508194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of skeletal muscle mass against progression from metabolically healthy to unhealthy phenotype.
    Lee MJ; Kim EH; Bae SJ; Choe J; Jung CH; Lee WJ; Kim HK
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):102-113. PubMed ID: 30290006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically healthy and unhealthy weight statuses, health issues and related costs: Findings from the 2013-2015 European Health Examination Survey in Luxembourg.
    Samouda H; Ruiz-Castell M; Karimi M; Bocquet V; Kuemmerle A; Chioti A; Dadoun F; Stranges S
    Diabetes Metab; 2019 Apr; 45(2):140-151. PubMed ID: 29249613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and changes in metabolically healthy overweight or obesity and risk of future diabetes: Niigata wellness study.
    Heianza Y; Kato K; Kodama S; Suzuki A; Tanaka S; Hanyu O; Sato K; Sone H
    Obesity (Silver Spring); 2014 Nov; 22(11):2420-5. PubMed ID: 25131796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolically healthy obesity: different prevalences using different criteria.
    Velho S; Paccaud F; Waeber G; Vollenweider P; Marques-Vidal P
    Eur J Clin Nutr; 2010 Oct; 64(10):1043-51. PubMed ID: 20628408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically healthy obese and unhealthy normal weight in Iranian adult population: Prevalence and the associated factors.
    Hajian-Tilaki K; Heidari B
    Diabetes Metab Syndr; 2018; 12(2):129-134. PubMed ID: 29196231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolically-healthy obesity and coronary artery calcification.
    Chang Y; Kim BK; Yun KE; Cho J; Zhang Y; Rampal S; Zhao D; Jung HS; Choi Y; Ahn J; Lima JA; Shin H; Guallar E; Ryu S
    J Am Coll Cardiol; 2014 Jun; 63(24):2679-86. PubMed ID: 24794119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
    Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.
    Ampuero J; Aller R; Gallego-Durán R; Banales JM; Crespo J; García-Monzón C; Pareja MJ; Vilar-Gómez E; Caballería J; Escudero-García D; Gomez-Camarero J; Calleja JL; Latorre M; Albillos A; Salmeron J; Aspichueta P; Lo Iacono O; Francés R; Benlloch S; Fernández-Rodríguez C; García-Samaniego J; Estévez P; Andrade RJ; Turnes J; Romero-Gómez M;
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1260-1270. PubMed ID: 30353552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between obesity and infarct size: insight into the obesity paradox.
    Cepeda-Valery B; Slipczuk L; Figueredo VM; Pressman GS; Morris DL; Lavie CJ; Romero-Corral A
    Int J Cardiol; 2013 Jul; 167(2):604-6. PubMed ID: 23102600
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient characteristics, health status, and health-related behaviors associated with obesity.
    Taira D; Gronley K; Chung R
    Hawaii Med J; 2004 May; 63(5):150-4. PubMed ID: 15216919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction and Update on Obesity and Cardiovascular Diseases 2018.
    Ortega FB; Lavie CJ
    Prog Cardiovasc Dis; 2018; 61(2):87-88. PubMed ID: 29981349
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontiers in research: obesity and health. Introduction.
    Zhang Y; Ren J
    Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):158-60. PubMed ID: 22288491
    [No Abstract]   [Full Text] [Related]  

  • 17. Obesity, high-molecular-weight (HMW) adiponectin, and metabolic risk factors: prevalence and gender-specific associations in Estonia.
    Eglit T; Ringmets I; Lember M
    PLoS One; 2013; 8(9):e73273. PubMed ID: 24039900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk.
    Cirulli ET; Guo L; Leon Swisher C; Shah N; Huang L; Napier LA; Kirkness EF; Spector TD; Caskey CT; Thorens B; Venter JC; Telenti A
    Cell Metab; 2019 Feb; 29(2):488-500.e2. PubMed ID: 30318341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with metabolically healthy status in obesity, overweight, and normal weight at baseline of ELSA-Brasil.
    Diniz MFHS; Beleigoli AMR; Ribeiro ALP; Vidigal PG; Bensenor IM; Lotufo PA; Duncan BB; Schmidt MI; Barreto SM
    Medicine (Baltimore); 2016 Jul; 95(27):e4010. PubMed ID: 27399079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, Metabolic Abnormality, and Progression of CKD.
    Yun HR; Kim H; Park JT; Chang TI; Yoo TH; Kang SW; Choi KH; Sung S; Kim SW; Lee J; Oh KH; Ahn C; Han SH;
    Am J Kidney Dis; 2018 Sep; 72(3):400-410. PubMed ID: 29728317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.